Dr Pepper Snapple Group Product 'Goes Pink' in Support of Susan G. Komen for t... ( Charity to Receive Portion of Procee...)

Dr Pepper Snapple Group Product 'Goes Pink' in Support of Susan G. Komen for the Cure(R)

Date:2/6/2009

Charity to Receive Portion of Proceeds from 40 Million Bottles Featuring Signature Pink Caps

PLANO, Texas, Feb. 6 /PRNewswire-FirstCall/ -- Dr Pepper Snapple Group, Inc. (NYSE: DPS) has joined the fight against breast cancer by topping select diet brands with signature pink Susan G. Komen for the Cure(R) bottle caps. The company will donate a portion of its proceeds to Susan G. Komen for the Cure, the world's largest breast cancer organization, with the goal of contributing $250,000 this year to battle the disease.

"Our partnership with Dr Pepper Snapple Group offers an easy and refreshing way for consumers to join us in our mission to end breast cancer forever," said Katrina McGhee, Vice President of Global Relations at Komen for the Cure.

By purchasing a 20-ounce or 2-liter bottle of a Dr Pepper Snapple Group product with a pink closure, consumers will generate a donation to Komen. From now through the end of March, the pink cap will appear on more than 40 million bottles of the company's diet brands including Diet Dr Pepper, Diet 7UP, Diet Cherry 7UP, Diet A&W, Diet Sunkist Soda, Diet Rite, Diet Canada Dry Ginger Ale, Diet RC, Diet Squirt and Diet Big Red.

"We are thrilled to give our consumers another way to give back to their community and help win the fight against breast cancer. Caring is at the heart of our business," said Larry Young, president and chief executive officer of Dr Pepper Snapple Group. "With more than 20,000 employees across North America, we are committed to our communities and organizations such as Susan G. Komen for the Cure that deliver the same values and principles that we do."

About Dr Pepper Snapple Group

Dr Pepper Snapple Group, Inc., (NYSE: '/>"/>

SOURCE Dr Pepper Snapple Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Sinus Buster Pepper Nasal Spray Moves Into Rite Aid Drug Stores
2. Peppermint Oil, Fiber Can Fight Irritable Bowel
3. Chilis Grill & Bar(R) to Donate 100 Percent of All Profits on Monday, Sept. 29 to St. Jude Childrens Research Hospital as Part of Annual Create-A-Pepper to Fight Childhood Cancer Campaign
4. FDA Expands Pepper Warning in Salmonella Outbreak
5. Mexican Peppers IDd as Salmonella Culprits
6. Abuelos Responds to CDC and FDA Warning on Certain Types of Raw Peppers and Tomatoes
7. July 11 Nomination Deadline Nears for Blue Cross Blue Shield of Michigan Annual Claude Pepper Community Service Awards
8. Common bowel problem linked to chili pepper pain receptor
9. Some like it hot! Structure of receptor for hot chili pepper and pain revealed
10. Pepperdine Business Plan Competition Awards $26,000 to MBA Teams
11. Nicotine, Chili Peppers Offer Post-Surgery Pain Relief

Post Your Comments:

(Date:5/22/2013)... from a large observational study reported at ... superior to heparin in the absence of ... patients with non-ST segment elevation acute coronary ... European and US NSTE-ACS guidelines currently recommend ... heparin plus GP IIb/IIIa receptor inhibitors in ...

(Date:5/22/2013)... MA (PRWEB) May 22, 2013 In ... hit the country’s fields and courts with donated ... Sports, a Massachusetts-based nonprofit dedicated to partnering with manufacturers ... is celebrating the donation of $8.8 million in sports ... more than a half-million kids outfitted for physical activity. ...

(Date:5/22/2013)... Following the success of last year’s ... Fit Body Boot Camp Kincardine has announced it will ... starting on June 3rd at its Kincardine fitness ... Kincardine, Ontario. , Fit Body Boot Camp’s 1,000 lb. ... community residents to lose a total of 1,000 pounds ...

(Date:5/22/2013)... Jersey City, NJ (PRWEB) May 22, 2013 ... governance, compliance, and management solutions for social enterprise ... Partners, LLC, a consulting firm based in Chicago, ... to integrate their products and provide best-in-class solutions ... productivity and improve collaboration. , AvePoint’s DocAve ...

(Date:5/22/2013)... adherence to appropriate medication therapy has been shown to ... 125,000 deaths in the U.S. every year are attributed ... estimated that between 33% and 69% of all medication-related ... a reality that costs the American health-care system approximately ... degree of medication non-adherence — and the consequences therefrom ...

Breaking Medicine News(10 mins):Health News:Registry questions superiority of bivalirudin over heparin 2 Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2 Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3 Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2 Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3 Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2 Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3 Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2

[0] Registry questions superiority of bivalirudin over heparin [0] Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity [0] Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity [0] AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration [0] Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance

... 25 Former NFL player and Dallas Cowboy,Jason Kaiser ... graduation ceremony. Kaiser earned the title of,valedictorian with a ... people in,this school and in my class especially," he ... Before enrolling in Parker College, Kaiser played professional football,for ...

... protein levels could key future treatments for Alzheimer,s , , ... finds that where protein-destroying machines reside in the brain,s ... a finding that may play a role in future ... Wake Forest University School of Medicine researchers studying mice ...

... his left eyebrow was possibly skin cancer , , FRIDAY, ... during his lifetime, historians have gone to great lengths ... of Franklin Delano Roosevelt, the 32nd president of the ... and heart disease is now well-documented. But a new ...

... QLT Inc. (NASDAQ: QLTI;,TSX: QLT) today reported financial results ... otherwise, all amounts are in U.S. dollars,and in accordance ... 2008, we were pleased to report the U.S. Food,and ... blood,monitoring from the Aczone(TM) label," said Bob Butchofsky, President ...

... Inc., (a wholly owned,subsidiary of Mentice AB), a ... the field of medicine, has recently appointed,Jeff Sirek ... Clinical,Applications Manager for the Americas., Jeff Sirek ... years with GE Healthcare in its Cardiovascular Ultrasound,Division ...

... Solutions, Inc. announced,today the addition of Dr. Marc ... serve as Vice President of Research and Development ... of spine,system/orthopedic development experience, most recently having directed,development ... Marc to Facet Solutions bolsters an already great,team, ...

Former Dallas Cowboy Honored as Parker College of Chiropractic Top 2008 Graduate When It Comes to Memory, It's All About Location FDR Might Have Had Melanoma QLT announces first quarter results for 2008 Mentice, Inc. Expands Its North American Sales and Clinical Presence With the Hiring of Jeff Sirek as Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas.Facet Solutions, Inc. Expands Executive Management Team

(Date:5/22/2013)... , May 22, 2013 PRNewswire – ... production of a vaccine candidate for the newly ... party laboratory using the iBioLaunch™ platform. This validation ... from initial antigen sequence information to purification of ... ) The iBioLaunch platform eliminates ...

(Date:5/22/2013)... WomanCare Global recently launched Simplant in ... training initiative attended by 90 health care providers. ... http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) Simplant, a long-acting ... subdermal implant composed of two thin, flexible, silicone ... form of the hormone progestin). These are inserted ...

(Date:5/21/2013)... BEIJING, May 21, 2013 Concord Medical Services ... CCM ), a leading specialty hospital management solution ... and diagnostic imaging centers in China and the parent ... results for the first quarter ended March 31, 2013 ... , Total net revenue, which consists of net revenues ...

[0] iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza [0] WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile [0] Concord Medical Reports First Quarter 2013 Financial Results

... (Nasdaq: IDEV ) today announced that it ... and Drug Administration (FDA) for,VALSTAR(R). VALSTAR, a sterile ... product approved by the FDA for therapy of,bacillus ... bladder. VALSTAR was removed from the market ...

... 17 Dendreon Corporation,(Nasdaq: DNDN ) today ... study,of NEUVENGE, an investigational active cellular immunotherapy, in ... Oncology. The article highlights,the safety profile, immune response ... breast cancer who have failed standard,therapy. "In ...

Cached Medicine Technology:Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 2 Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 3 Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 4 Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 2 Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 3 Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 4

Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

Netromycin, Random Level Netilmicin, Random Level Neopterin Level Neonatal 5 Drug Panel, Meconium